Thousand Oaks, CA4 Active Studies

Ankylosing Spondylitis Clinical Trials in Thousand Oaks, CA

Find 4 actively recruiting ankylosing spondylitis clinical trials in Thousand Oaks, CA. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
375
Enrolling

Recruiting Ankylosing Spondylitis Studies in Thousand Oaks

RecruitingThousand Oaks, CANCT04123795

A Study to Evaluate the Pharmacokinetics, Safety, and Effectiveness of Certolizumab Pegol in Children With Moderate to Severe Chronic Plaque Psoriasis

The purpose of the study is to evaluate the pharmacokinetic (PK) of certolizumab pegol (CZP) in study participants aged 6 to 17 years with moderate to severe chronic plaque psoriasis (PSO) in order to...

150 participants
UCB Biopharma SRL
View Study Details
RecruitingThousand Oaks, CANCT03997786

A Study of Tildrakizumab in Pediatric Subjects With Chronic Plaque Psoriasis

The study has been designed with three components. Part A is an open label PK study followed by a randomized trial component (Part B) followed by open label Long Term Extension (LTE). The initial PK ...

130 participants
Sun Pharmaceutical Industries Limited
View Study Details
RecruitingThousand Oaks, CANCT06088199

A Study of Apremilast in Pediatric Participants in Children With Mild to Moderate Plaque Psoriasis

The primary objective of this post-marketing study is to assess the safety and tolerability of apremilast in pediatric participants (ages 6 through 17 years) with mild to moderate plaque psoriasis....

50 participants
Amgen
View Study Details
RecruitingThousand Oaks, CANCT03987763

A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque Psoriasis

This study is to evaluate the safety, the systemic exposure of halobetasol propionate (HP), and the hypothalamic-pituitary-adrenal (HPA) axis suppression potential for topically applied IDP-122 lotion...

45 participants
Bausch Health Americas, Inc.
View Study Details

About Ankylosing Spondylitis Clinical Trials in Thousand Oaks

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 4 ankylosing spondylitis clinical trials recruiting participants in Thousand Oaks, CA. These studies are seeking a combined 375 participants. Research is being sponsored by UCB Biopharma SRL, Sun Pharmaceutical Industries Limited, Amgen and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Thousand Oaks — FAQ

Are there ankylosing spondylitis clinical trials in Thousand Oaks?

Yes, there are 4 ankylosing spondylitis clinical trials currently recruiting in Thousand Oaks, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Thousand Oaks?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Thousand Oaks research site will contact you about next steps.

Are clinical trials in Thousand Oaks free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Thousand Oaks studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 4 active trials in Thousand Oaks are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated March 2, 2026 from ClinicalTrials.gov